Vestigial Like 3 (VGLL3) (Middle Region) Peptide
VGLL3
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN986065
Quick Overview for Vestigial Like 3 (VGLL3) (Middle Region) Peptide (ABIN986065)
Target
VGLL3
(Vestigial Like 3 (VGLL3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-VGLL3 antibody (Catalog #: ARP55341_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- VGLL3 (Vestigial Like 3 (VGLL3))
-
Background
-
VGLL3 belongs to the vestigial family. It may act as a specific coactivator for the mammalian TEFs.
Alias Symbols: DKFZp686O1845, FLJ38507, VGL-3, VGL3
Protein Size: 326 -
Molecular Weight
- 36 kDa
-
Gene ID
- 389136
-
NCBI Accession
- NM_016206, NP_057290
-
UniProt
- A8MV65
Target
-
You are here:
